For help on how to get the results you want, see our search tips.
303 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Maximum residue limits Remove Maximum residue limits filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Human medicine European public assessment report (EPAR): Zinbryta
daclizumab, Multiple Sclerosis
Date of authorisation: 01/07/2016,
, Revision: 8, Withdrawn, Last updated: 28/06/2018
-
List item
Human medicine European public assessment report (EPAR): Olysio
simeprevir, Hepatitis C, Chronic
Date of authorisation: 14/05/2014,, Revision: 13, Withdrawn, Last updated: 23/05/2018
-
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR AlSap 1
bluetongue-virus serotype-1 antigen, Sheep, Cattle
Date of authorisation: 17/12/2010, Revision: 4, Withdrawn, Last updated: 17/05/2018 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR Alsap 8
bluetongue virus serotype 8 antigen, Sheep, Cattle
Date of authorisation: 17/03/2009, Revision: 5, Withdrawn, Last updated: 16/05/2018 -
List item
Human medicine European public assessment report (EPAR): Vibativ
telavancin, Pneumonia, Bacterial, Cross Infection
Date of authorisation: 02/09/2011,, Revision: 10, Withdrawn, Last updated: 16/05/2018
-
List item
Human medicine European public assessment report (EPAR): Insulin Human Winthrop
insulin human, Diabetes Mellitus
Date of authorisation: 17/01/2007, Revision: 15, Withdrawn, Last updated: 30/04/2018 -
List item
Human medicine European public assessment report (EPAR): Evarrest
human fibrinogen, human thrombin, Hemostasis
Date of authorisation: 25/09/2013,, Revision: 4, Withdrawn, Last updated: 03/04/2018
-
List item
Human medicine European public assessment report (EPAR): IDflu
influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type), Influenza, Human, Immunization
Date of authorisation: 24/02/2009, Revision: 13, Withdrawn, Last updated: 29/03/2018 -
List item
Human medicine European public assessment report (EPAR): Tasermity
sevelamer hydrochloride, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 25/02/2015, Revision: 4, Withdrawn, Last updated: 27/03/2018 -
List item
Human medicine European public assessment report (EPAR): Ristempa
pegfilgrastim, Neutropenia
Date of authorisation: 13/04/2015,, Revision: 3, Withdrawn, Last updated: 07/03/2018
-
List item
Human medicine European public assessment report (EPAR): LeukoScan
sulesomab, Osteomyelitis, Radionuclide Imaging
Date of authorisation: 14/02/1997, Revision: 7, Withdrawn, Last updated: 09/02/2018 -
List item
Human medicine European public assessment report (EPAR): Libertek
roflumilast, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 28/02/2011, Revision: 11, Withdrawn, Last updated: 08/02/2018 -
List item
Human medicine European public assessment report (EPAR): Daliresp
roflumilast, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 28/02/2011, Revision: 9, Withdrawn, Last updated: 06/02/2018 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino
clopidogrel, Peripheral Vascular Diseases, Acute Coronary Syndrome, Myocardial Infarction, Stroke
Date of authorisation: 28/07/2009,
, Revision: 6, Withdrawn, Last updated: 04/01/2018
-
List item
Human medicine European public assessment report (EPAR): Optimark
gadoversetamide, Magnetic Resonance Imaging
Date of authorisation: 23/07/2007, Revision: 14, Withdrawn, Last updated: 11/12/2017 -
List item
Human medicine European public assessment report (EPAR): Somatropin Biopartners
somatropin, Growth
Date of authorisation: 05/08/2013, Revision: 3, Withdrawn, Last updated: 01/12/2017 -
List item
Human medicine European public assessment report (EPAR): Prevenar
pneumococcal oligosaccharide serotype 18C, Pneumococcal polysaccharide serotype 19F, Pneumococcal polysaccharide serotype 23F, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 6B, Pneumococcal polysaccharide serotype 9V, Pneumococcal polysaccharide serotype 14, Pneumococcal Infections, Immunization
Date of authorisation: 02/02/2001, Revision: 23, Withdrawn, Last updated: 24/11/2017 -
List item
Human medicine European public assessment report (EPAR): Glybera
alipogene tiparvovec, Hyperlipoproteinemia Type I
Date of authorisation: 25/10/2012,, 
, 
, Revision: 8, Withdrawn, Last updated: 30/10/2017
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva Pharma (previously Clopidogrel HCS)
clopidogrel (as hydrochloride), Myocardial Infarction, Peripheral Vascular Diseases, Stroke
Date of authorisation: 21/09/2009,, Revision: 9, Withdrawn, Last updated: 24/10/2017
-
List item
Human medicine European public assessment report (EPAR): Zontivity
vorapaxar sulfate, Myocardial Infarction
Date of authorisation: 19/01/2015,, Revision: 2, Withdrawn, Last updated: 20/09/2017
-
List item
Veterinary medicine European public assessment report (EPAR): Recuvyra
fentanyl, Dogs
Date of authorisation: 06/10/2011, Revision: 4, Withdrawn, Last updated: 12/07/2017 -
List item
Human medicine European public assessment report (EPAR): Removab
Catumaxomab, Ascites, Cancer
Date of authorisation: 20/04/2009, Revision: 5, Withdrawn, Last updated: 12/07/2017 -
List item
Human medicine European public assessment report (EPAR): Sabervel
irbesartan, Hypertension
Date of authorisation: 13/04/2012,, Revision: 2, Withdrawn, Last updated: 29/06/2017
-
List item
Human medicine European public assessment report (EPAR): Optaflu
influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type), Influenza, Human, Immunization
Date of authorisation: 01/06/2007, Revision: 16, Withdrawn, Last updated: 27/06/2017 -
List item
Human medicine European public assessment report (EPAR): Vitekta
elvitegravir, HIV Infections
Date of authorisation: 13/11/2013,, Revision: 4, Withdrawn, Last updated: 29/05/2017